Viibryd and Chronic thyroiditis - a phase IV clinical study of FDA data

Summary:

Chronic thyroiditis is reported only by a few people who take Viibryd.

The phase IV clinical study analyzes which people take Viibryd and have Chronic thyroiditis. It is created by eHealthMe based on reports of 9,428 people who have side effects while taking Viibryd from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Feb, 07, 2023

9,428 people reported to have side effects when taking Viibryd.
Among them, 2 people (0.02%) have Chronic thyroiditis.

What is Viibryd?

Viibryd has active ingredients of vilazodone hydrochloride. It is often used in depression. eHealthMe is studying from 10,284 Viibryd users for its effectiveness, alternative drugs and more.

What is Chronic thyroiditis?

Chronic thyroiditis (long lasting inflammation of thyroid gland) is found to be associated with 1,274 drugs and 951 conditions by eHealthMe.

Number of Viibryd and Chronic thyroiditis reports submitted per year:

Could Viibryd cause Chronic thyroiditis?

Gender of people who have Chronic thyroiditis when taking Viibryd *:

female: 100 %
male: 0.0 %

Common drugs people take besides Viibryd *:

Common side effects people have besides Chronic thyroiditis *:

Joint Pain: 1 person, 50.00%
Heart Palpitations (feelings or sensations that your heart is pounding or racing): 1 person, 50.00%
Fibromyalgia (a long-term condition which causes pain all over the body): 1 person, 50.00%

Common conditions people have *:

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 1 person, 50.00%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 1 person, 50.00%

* Approximation only. Some reports may have incomplete information.

Do you take Viibryd and have Chronic thyroiditis?

Check whether Chronic thyroiditis is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Chronic thyroiditis and when was it recovered:

Chronic thyroiditis in Viibryd

Expand to all the drugs that have ingredients of vilazodone hydrochloride:

Chronic thyroiditis and drugs with ingredients of vilazodone hydrochloride

Alternative drugs to, pros and cons of Viibryd:

Viibryd (10,284 reports)

Common Viibryd side effects:

Diarrhea: 878 reports
Stress and anxiety: 717 reports
Insomnia (sleeplessness): 663 reports
Headache (pain in head): 585 reports
Dizziness: 536 reports
Depression: 518 reports
Fatigue (feeling of tiredness): 506 reports

Browse all side effects of Viibryd:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Chronic thyroiditis treatments and more:

Chronic thyroiditis (11,615 reports)

COVID vaccines that are related to Chronic thyroiditis:

Common drugs associated with Chronic thyroiditis:

All the drugs that are associated with Chronic thyroiditis:

Chronic thyroiditis (1,274 drugs)

Common conditions associated with Chronic thyroiditis:

All the conditions that are associated with Chronic thyroiditis:

Chronic thyroiditis (951 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on vilazodone hydrochloride (the active ingredients of Viibryd) and Viibryd (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.